227 related articles for article (PubMed ID: 33768245)
41. Levcromakalim provokes an acute rapid-onset migraine-like phenotype without inducing cortical spreading depolarization.
Alpay B; Cimen B; Akaydin E; Bolay H; Sara Y
J Headache Pain; 2023 Jul; 24(1):93. PubMed ID: 37488480
[TBL] [Abstract][Full Text] [Related]
42. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
Lipton RB; Dodick DW; Silberstein SD; Saper JR; Aurora SK; Pearlman SH; Fischell RE; Ruppel PL; Goadsby PJ
Lancet Neurol; 2010 Apr; 9(4):373-80. PubMed ID: 20206581
[TBL] [Abstract][Full Text] [Related]
43. The potassium channel opener levcromakalim causes expansive remodelling of experimental vein grafts.
Wales L; Gosling M; Taylor GW; Davies AH; Powell JT
J Vasc Surg; 2006 Jul; 44(1):159-65. PubMed ID: 16828441
[TBL] [Abstract][Full Text] [Related]
44. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
45. Calcitonin gene-related peptide causes migraine aura.
Al-Khazali HM; Ashina H; Wiggers A; Rose K; Iljazi A; Christensen RH; Schytz HW; Amin FM; Ashina M
J Headache Pain; 2023 Sep; 24(1):124. PubMed ID: 37679723
[TBL] [Abstract][Full Text] [Related]
46. Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura.
Hougaard A; Amin FM; Christensen CE; Younis S; Wolfram F; Cramer SP; Larsson HBW; Ashina M
Brain; 2017 Jun; 140(6):1633-1642. PubMed ID: 28430860
[TBL] [Abstract][Full Text] [Related]
47. Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura.
Christiansen I; Thomsen LL; Daugaard D; Ulrich V; Olesen J
Cephalalgia; 1999 Sep; 19(7):660-7; discussion 626. PubMed ID: 10524660
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
49. Adenosine causes short-lasting vasodilation and headache but not migraine attacks in migraine patients: a randomized clinical trial.
Thuraiaiyah J; Al-Karagholi MA; Elbahi FA; Zhuang ZA; Ashina M
Pain; 2023 May; 164(5):1118-1127. PubMed ID: 36251971
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
51. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.
Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J
Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422
[TBL] [Abstract][Full Text] [Related]
52. Isoflurane pretreatment preserves adenosine triphosphate-sensitive K(+) channel function in the human artery exposed to oxidative stress caused by high glucose levels.
Kinoshita H; Matsuda N; Iranami H; Ogawa K; Hatakeyama N; Azma T; Kawahito S; Yamazaki M
Anesth Analg; 2012 Jul; 115(1):54-61. PubMed ID: 22467893
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of frovatriptan as compared to other triptans in migraine with aura.
Evers S; Savi L; Omboni S; Lisotto C; Zanchin G; Pinessi L
J Headache Pain; 2015; 16():514. PubMed ID: 25916333
[TBL] [Abstract][Full Text] [Related]
54. Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura?
Dowson A
Eur Neurol; 1996; 36 Suppl 2():28-31. PubMed ID: 8791030
[TBL] [Abstract][Full Text] [Related]
55. Vasodilator effects of KRN2391, levcromakalim and 3-morpholino-sydnonimin in human pial and omental arteries.
Petersson J; Ryman T; Högestätt ED
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):68-73. PubMed ID: 10935535
[TBL] [Abstract][Full Text] [Related]
56. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
57. Variability of clinical features in attacks of migraine with aura.
Hansen JM; Goadsby PJ; Charles AC
Cephalalgia; 2016 Mar; 36(3):216-24. PubMed ID: 25944814
[TBL] [Abstract][Full Text] [Related]
58. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
Ploug KB; Boni LJ; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
[TBL] [Abstract][Full Text] [Related]
59. Effect of the H
Vollesen LH; Guo S; Andersen MR; Ashina M
Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750
[TBL] [Abstract][Full Text] [Related]
60. Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.
Guo S; Vollesen AL; Hansen RD; Esserlind AL; Amin FM; Christensen AF; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):125-135. PubMed ID: 26994299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
